Skip to content

Uterine Preservation With Acar's Atony Suture for Postpartum Uterine Hemorrhage

Uterine Preservation With Acar's Atony Suture for Postpartum Uterine Atony

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06353074
Enrollment
16
Registered
2024-04-08
Start date
2021-01-01
Completion date
2023-11-30
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Hemorrhage, Uterine Atony With Hemorrhage

Keywords

Cesarean section, compression suture, postpartum hemorrhage

Brief summary

This study is aimed to show effectiveness of a new suture technique to stop postpartum uterine bleeding due to uterine atony.

Detailed description

A retrospective study of all women received Acar's uterine compressive atony suture between January 2021-November 2023 at a single tertiary hospital with approximately 4000 deliveries per year, was performed. The local protocol for PPH due to uterine atony is uterine manual compression, 20 IU of intravenous oxytocin in 500 cc of normal saline at 500 cc/h; 800 µg of misoprostol inserted per rectal. If additional treatment is needed, carbetocin 100mcg in 100 cc of normal saline or tranexamic acid in different posologies are used. If uterine atony persists, intrauterine balloon tamponade or uterine compressive sutures were applied at the discretion of the physician and according to mode of delivery. When uterine compressive suture was performed, original Acar's atony suture was applied.

Interventions

None listed

Sponsors

Necmettin Erbakan University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years

Inclusion criteria

* women without systemic disease

Exclusion criteria

* cardiac disease * rheumatological disease

Design outcomes

Primary

MeasureTime frameDescription
Postpartum hysterectomy and/or intensive care unit need ratioSince first operation to discharge from hospital assessed up to 5 daysThe need for hysterectomy or massive transfusion because of unstoppable and mortal bleeding

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026